🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts stated the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.

Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down problematic content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the platform secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, populated with images of weight loss, positive reviews and step-by-step guides for preparing or administering at residence.

After minutes of joining one community, a vendor shared contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Costs

Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially significant medical dangers”.